The slip
PARKINSON RECEIPTno. 7877
23 Oct 2026, 20:05 UTCdopamine neurons, braak
predictionSV2B in dopamine neurons tracks Braak Lewy-body stage
registeredaa2adc8bf9ac1b1d
discovery+0.61 p=0.078 n=9
replication-0.05 p=0.893 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.61, p 0.078)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTc22d9be496762bd8b09f0627…
follows c08f114cf1c3…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7877: SV2B in dopamine neurons, braak
- power
- full sample +0.26 (p 0.298, n 18), 95% CI -0.24 to +0.65. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.27 (p 0.281, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.24 (p 0.328, n 18). could be the mix.
- skeptic
- leave-one-out range +0.17 to +0.40, sign flips 0; without severely affected donors +0.26 (p 0.298, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SV2B in dopamine neurons.
case closed: nothing better to follow up.